Masahiro Okada MD, Presenter: Nothing to Disclose

Tetsuya Wakayama PhD, Abstract Co-Author: Employee, General Electric Company

Tomomi Koga, Abstract Co-Author: Nothing to Disclose

Nanae Tsuchiya, Abstract Co-Author: Nothing to Disclose

Takamichi Murakami MD, PhD, Abstract Co-Author: Nothing to Disclose

Sadayuki Murayama MD, PhD, Abstract Co-Author: Nothing to Disclose

1. To define advanced MR sequences in liver imaging for fat, fibrosis and iron. 2. To introduce new liver MR imaging for the analysis of liver dysfunction. 3. To recognize pitfalls of liver MR imaging.  

1. Advanced liver imaging for liver parenchymal imaging  a) MR spectroscopy of fat  b) Fat fraction analysis and T2* relaxometry to investigate deposit of fat and iron  c) Dixon technique for water and fat imaging  d) Liver-specific contrast agent (Gd-EOB-DTPA) to estimate liver function  e) Time intensity curve analysis after Gd-EOB-DTPA injection   f) T1 relaxometry for diffuse liver disease  g)  T1 relaxometry versus US elastography for liver fibrosis  h) MR elastography 2. Presentation of liver imaging a) Fatty liver, Non-alcoholic steatohepatitis (NASH) b) Chronic hepatitis c)  Liver cirrhosis 3. Strategy of therapy in patients with hepatocellular carcinoma and liver dysfunction 4. Pitfalls of MR imaging to image liver function   

http://abstract.rsna.org/uploads/2014/14002548/14002548_s13p.pdf

Okada, M, Wakayama, T, Koga, T, Tsuchiya, N, Murakami, T, Murayama, S, Liver Dysfunction Imaging on MRI: Are You Working on Quantifying Fat, Fibrosis and Iron of the Liver?.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14002548.html